CX Institutional’s Leidos LDOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.7M Buy
95,712
+94,926
+12,077% +$11.9M 0.32% 74
2026
Q2
$81K Sell
786
-800
-50% -$106K ﹤0.01% 903
2026
Q1
$247K Sell
1,586
-129
-8% -$23.2K 0.01% 663
2025
Q4
$309K Buy
1,715
+212
+14% +$40.2K 0.01% 569
2025
Q3
$284K Buy
1,503
+62
+4% +$10.8K 0.01% 586
2025
Q2
$227K Buy
1,441
+48
+3% +$7.1K 0.01% 588
2025
Q1
$188K Buy
+1,393
New +$194K 0.01% 616
2023
Q3
– Sell
-36,156
Closed -$3.2M – 521
2023
Q2
$3.2M Sell
36,156
-8,057
-18% -$686K 0.17% 177
2023
Q1
$4.11M Buy
+44,213
New +$4.28M 0.22% 147
2022
Q3
– Sell
-378
Closed -$38K – 846
2022
Q2
$38K Buy
+378
New +$39.2K ﹤0.01% 731
2021
Q4
– Sell
-46
Closed -$4K – 665
2021
Q3
$4K Sell
46
-239
-84% -$23.7K ﹤0.01% 874
2021
Q2
$29K Sell
285
-29
-9% -$2.98K ﹤0.01% 669
2021
Q1
$30K Sell
314
-20,571
-98% -$2.08M ﹤0.01% 600
2020
Q4
$2.2M Sell
20,885
-8,025
-28% -$769K 0.21% 144
2020
Q3
$2.58M Buy
28,910
+28,875
+82,500% +$2.61M 0.28% 106
2020
Q2
$3K Sell
35
-9
-20% -$886 ﹤0.01% 721
2020
Q1
$4K Buy
+44
New +$4.44K ﹤0.01% 585

Other funds holding LDOS

CX Institutional's LDOS Position: Q3 2026 in Review

CX Institutional increased its Leidos (LDOS) stake by 12,077% in Q3 2026, buying an estimated $11.9M and bringing the position to 95,712 shares worth $11.7M. The position accounts for 0.32% of the portfolio, ranked #74.

CX Institutional first reported a position in LDOS in Q1 2020 and has held it in 17 quarters since. 128 funds tracked by Wall St. Rank hold LDOS as of Q3 2026.

  • CX Institutional held 95,712 shares of Leidos worth $11.7M as of Q3 2026.
  • CX Institutional bought 94,926 Leidos shares in Q3 2026, an estimated $11.9M.
  • Leidos made up 0.32% of CX Institutional's portfolio in Q3 2026, its #74 holding.
  • CX Institutional first reported a position in Leidos in Q1 2020 and has held it in 17 quarters since.
  • 128 funds tracked by Wall St. Rank held Leidos as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.